
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lentinan is a beta-1,3-glucan polysaccharide extracted from shiitake mushrooms that activates immune cells including macrophages and T-lymphocytes. This bioactive compound demonstrates immunomodulatory effects by binding to complement receptor 3 and dectin-1 receptors on immune cells.

Reported Benefits (Provisional)
Origin & History

Lentinan is a beta-glucan extracted from the Shiitake mushroom, primarily grown in East Asia. It is produced through hot water extraction to isolate the active compound.
Research Narrative (Provisional)
Lentinan has been studied in several clinical trials, particularly in Japan, for its immune-modulating effects and potential benefits in cancer therapy. Meta-analyses suggest it may improve survival in certain cancers.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Lentinan is a high-molecular-weight β-(1→3)-D-glucan with β-(1→6) branching, isolated from the fruiting bodies and mycelium of Lentinula edodes (Shiitake mushroom). As a purified polysaccharide, its nutritional profile is centered on its bioactive carbohydrate structure rather than broad macronutrient content. Key details: Bioactive Compound: β-(1,3)-(1,6)-D-glucan (lentinan), typically comprising 1–2% of dried shiitake mushroom weight (~10–20 mg per gram of dried fruiting body). Purified pharmaceutical-grade lentinan is administered at doses of 1–10 mg (injectable) or 100–500 mg orally as a dietary supplement. Molecular Weight: Approximately 400,000–800,000 Da in its native triple-helix conformation, which is critical for biological activity. Macronutrient Context (whole dried shiitake per 100 g): Protein ~10–18 g, Fat ~1–2 g, Total dietary fiber ~25–45 g (of which soluble β-glucans constitute approximately 2–5 g), Carbohydrates ~60–75 g, Energy ~270–300 kcal. Micronutrients (whole shiitake context): Vitamin D2 (ergocalciferol) ~0.4–46 µg/100 g (highly variable, increases dramatically with UV exposure to >1000 IU/100 g), B-vitamins including niacin (B3) ~14 mg, pantothenic acid (B5) ~22 mg, riboflavin (B2) ~1.3 mg, thiamine (B1) ~0.3 mg per 100 g dried. Minerals: Selenium ~6–46 µg, Copper ~0.9–5.0 mg, Zinc ~1–8 mg, Manganese ~0.8–2.0 mg, Potassium ~1500–1800 mg, Phosphorus ~280–400 mg, Iron ~1–5 mg per 100 g dried. Additional Bioactives: Eritadenine (~50–70 mg/100 g dried, cholesterol-lowering compound), ergothioneine (~1–5 mg/100 g, antioxidant amino acid), lenthionine (volatile sulfur compound responsible for flavor and mild antimicrobial effects), ergosterol (provitamin D2, ~50–100 mg/100 g dried). Bioavailability Notes: Oral bioavailability of lentinan is relatively low (~1–5%) due to its large molecular weight and degradation in the GI tract; however, gut-associated lymphoid tissue (GALT) interaction mediates significant immunomodulatory effects even with oral dosing. Micronization and particulate formulations improve absorption. The triple-helix conformation is essential for receptor binding (Dectin-1, CR3/complement receptor 3 on macrophages); denaturation reduces bioactivity. Co-administration with vitamin C or acidic environments may partially degrade the helix. Whole mushroom matrix consumption enhances bioavailability of associated micronutrients (e.g., vitamin D2 absorption improved with dietary fat). Eritadenine is well-absorbed orally with direct hepatic cholesterol-lowering action.
Reported Mechanism (Provisional)
Lentinan binds to complement receptor 3 (CR3) and dectin-1 receptors on macrophages, dendritic cells, and neutrophils, triggering immune cascade activation. This binding stimulates cytokine production including interleukin-1β, tumor necrosis factor-α, and interferon-γ. The compound also activates the alternative complement pathway and enhances natural killer cell cytotoxicity through Toll-like receptor signaling.
Clinical Narrative (Provisional)
Human clinical trials with lentinan doses of 2-10mg administered intravenously show significant immune enhancement in cancer patients, with studies involving 50-200 participants. Oral supplementation studies using 1-3g daily of shiitake extract containing lentinan demonstrate modest cholesterol reductions of 7-12% over 4-12 weeks. Most research focuses on intravenous administration as an adjuvant cancer therapy, with limited high-quality data on oral supplementation effectiveness.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







